Business spin - off
搜索文档
ABF's Share Price Dips On Weak FY Results, Primark Split Considered
Forbes· 2025-11-04 17:05
Photo by Mike Kemp/In Pictures via Getty ImagesIn Pictures via Getty ImagesAssociated British Food’s (ABF) share price reversed slightly on Tuesday, as news of a possible split of its Primark and food businesses failed to offset softer-than-expected full year results.At £22.57 per share, ABF shares were last trading 1% lower on the day.ABF’s group revenues dropped 3% over the 52 weeks to 13 September, to £19.5 billion. The FTSE 100 company said that “growth in Retail [was] offset by a decline in Sugar.”At c ...
Ananym suggests Baker Hughes spin out its oil services equipment business
Reuters· 2025-10-22 01:38
公司战略与股东诉求 - Ananym Capital希望能源与技术公司贝克休斯分拆其油田服务与设备业务 [1] - 该举措被认为可能推动公司股价至少上涨60% [1]
Johnson & Johnson Beats Earnings Expectations, Plans Orthopaedics Spin-Off
Financial Modeling Prep· 2025-10-15 03:59
第三季度财务业绩 - 第三季度每股收益为280美元,超出市场普遍预期的276美元 [1] - 第三季度营收同比增长68%至2399亿美元,高于市场预期的2376亿美元 [1] 全年业绩指引 - 重申2025年全年每股收益指引为1080美元至1090美元,与市场普遍预期的1085美元一致 [2] - 调整后运营每股收益预计为1063美元至1073美元 [2] - 全年营收指引小幅上调至935亿美元至939亿美元,此前指引区间为932亿美元至936亿美元 [2] 骨科业务分拆战略 - 宣布计划分拆其骨科业务部门,以精简运营并聚焦于创新医药和医疗技术领域的高增长、高利润率业务 [3] - 该举措旨在提升资本效率并改善长期盈利质量 [3]
Johnson & Johnson to spin off orthopedics unit after raising 2025 sales forecast
Invezz· 2025-10-14 20:56
Johnson & Johnson on Tuesday lifted its 2025 revenue guidance after posting stronger-than-expected third-quarter earnings and revealed plans to spin off its orthopedics business into a standalone comp... ...
Sony: Focusing On Core Products, Faces Tariff Risk
Seeking Alpha· 2025-08-23 04:24
公司战略调整 - 索尼集团计划于2025年9月分拆金融服务业[1] - 分拆释放的资本将重新投入核心娱乐和图像传感器业务[1] - 该举措旨在提升核心业务的增长潜力[1] 分析师背景 - 分析师Michael Del Monte拥有超过5年买方股票分析经验[1] - 分析师曾在专业服务领域工作超过十年[1] - 覆盖行业包括油气、工业、信息技术和可选消费等多个领域[1] 研究方法论 - 投资建议基于整体投资生态系统分析[1] - 采用跨行业综合研究方法而非孤立分析单个公司[1]
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
Seeking Alpha· 2025-05-26 11:24
公司评级与业务动态 - 分析师给予美敦力(NYSE: MDT)"买入"评级 主要基于其心脏消融解决方案的业务优势 [1] - 公司分拆糖尿病业务的决策被视为股价短期催化剂 [1] 分析师持仓披露 - 分析师通过股票、期权或其他衍生工具持有美敦力多头头寸 [1]